Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
OMCL — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

6.32

Margin Of Safety %

47

Put/Call OI Ratio

0.93

EPS Next Q Diff

0.25

EPS Last/This Y

1.71

EPS This/Next Y

0.34

Price

34.54

Target Price

57.43

Analyst Recom

1.25

Performance Q

-26.49

Upside

-95.9%

Beta

0.82

Ticker: OMCL




16 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09OMCL39.830.920.00985
2026-03-10OMCL39.010.915.00986
2026-03-11OMCL37.490.910.00988
2026-03-12OMCL35.110.912.90991
2026-03-13OMCL35.10.912.90991
2026-03-17OMCL35.10.920.421011
2026-03-18OMCL34.010.935.00999
2026-03-20OMCL33.080.910.63977
2026-03-25OMCL34.930.910.00938
2026-03-26OMCL35.210.910.00940
2026-03-27OMCL32.750.91999.99937
2026-03-30OMCL32.370.910.34938
2026-03-31OMCL33.330.940.00929
2026-04-01OMCL33.980.940.00929
2026-04-06OMCL34.10.900.00952
2026-04-07OMCL34.540.930.07934
DateSymbolLatestP/C OIP/C VolTotal OI
16 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09OMCL39.8325.5- 1.75
2026-03-10OMCL39.0225.5- 1.75
2026-03-11OMCL37.4725.5- 1.75
2026-03-12OMCL35.1025.5- 1.75
2026-03-13OMCL34.4025.5- 1.75
2026-03-17OMCL35.0823.6- 1.75
2026-03-18OMCL34.0123.6- 1.75
2026-03-19OMCL33.4023.6- 1.75
2026-03-20OMCL33.0923.6- 1.75
2026-03-23OMCL34.3123.6- 1.75
2026-03-24OMCL34.4623.6- 1.75
2026-03-25OMCL34.9423.6- 1.75
2026-03-26OMCL35.2223.6- 1.75
2026-03-27OMCL32.7223.6- 1.75
2026-03-30OMCL32.3723.6- 1.75
2026-03-31OMCL33.3823.6- 1.75
2026-04-01OMCL33.9723.6- 1.75
2026-04-02OMCL34.1623.6- 1.75
2026-04-06OMCL34.1323.6- 1.75
2026-04-07OMCL34.5423.6- 1.75
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09OMCL-3.753.705.74
2026-03-10OMCL-3.753.705.74
2026-03-11OMCL-3.753.706.06
2026-03-12OMCL-3.753.706.06
2026-03-13OMCL-3.753.706.06
2026-03-18OMCL-3.993.686.06
2026-03-19OMCL-3.993.686.06
2026-03-20OMCL-3.993.686.06
2026-03-23OMCL-3.993.656.06
2026-03-24OMCL-3.993.656.06
2026-03-25OMCL-3.993.656.32
2026-03-26OMCL-3.993.656.32
2026-03-27OMCL-3.993.656.32
2026-03-30OMCL-3.993.656.32
2026-03-31OMCL-3.993.656.32
2026-04-01OMCL-3.993.656.32
2026-04-02OMCL-3.993.656.32
2026-04-06OMCL-3.991.686.32
2026-04-07OMCL-3.991.686.32
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.16

Avg. EPS Est. Current Quarter

0.32

Avg. EPS Est. Next Quarter

0.41

Insider Transactions

-3.99

Institutional Transactions

1.68

Beta

0.82

Average Sales Estimate Current Quarter

304

Average Sales Estimate Next Quarter

304

Fair Value

50.62

Quality Score

44

Growth Score

67

Sentiment Score

81

Actual DrawDown %

81.6

Max Drawdown 5-Year %

-86.6

Target Price

57.43

P/E

798.61

Forward P/E

16.53

PEG

1.03

P/S

1.32

P/B

1.26

P/Free Cash Flow

18.56

EPS

0.04

Average EPS Est. Cur. Y​

1.75

EPS Next Y. (Est.)

2.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

0.17

Relative Volume

0.5

Return on Equity vs Sector %

-27.3

Return on Equity vs Industry %

-9.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

OMCL Healthcare
$34.50
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
17/25
Volume
11/15
Valuation
20/20
TP/AR
4/10
Options
2/10
RSI
42.8
Range 1M
29.8%
Sup Dist
2.6%
🚀
Momentum Growth
Ride accelerating trends
N/A
27 /100
WEAK
Momentum
0/25
Growth
12/30
Estimates
5/20
Inst/Vol
4/15
Options
6/10
EPS Yr
8.1%
EPS NY
19.2%
52W%
36.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +83.3% upside
Quality
6/30
Valuation
28/30
Growth
7/25
Stability
7/10
LT Trend
0/5
Upside
+83.3%
Quality
44
MoS
47%
Omnicell, Inc.
Sector: Healthcare
Industry: Health Information Services
Employees: 3580
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
OMCL

Latest News

Caricamento notizie per OMCL
stock quote shares OMCL – Omnicell, Inc. Stock Price stock today
news today OMCL – Omnicell, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OMCL – Omnicell, Inc. yahoo finance google finance
stock history OMCL – Omnicell, Inc. invest stock market
stock prices OMCL premarket after hours
ticker OMCL fair value insiders trading